Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
352 GBX | +4.14% | +13.55% | +24.38% |
Financials (USD)
Sales 2024 * | 686M | Sales 2025 * | 842M | Capitalization | 3.76B |
---|---|---|---|---|---|
Net income 2024 * | -107M | Net income 2025 * | -2M | EV / Sales 2024 * | 5.19 x |
Net cash position 2024 * | 199M | Net cash position 2025 * | 306M | EV / Sales 2025 * | 4.1 x |
P/E ratio 2024 * |
-32.5
x | P/E ratio 2025 * |
684
x | Employees | 1,988 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 52.37% |
Latest transcript on HUTCHMED (China) Limited
1 day | +4.14% | ||
1 week | +13.55% | ||
Current month | +18.32% | ||
1 month | +21.38% | ||
3 months | +58.92% | ||
6 months | +13.73% | ||
Current year | +24.38% |
Managers | Title | Age | Since |
---|---|---|---|
Wei Guo Su
CEO | Chief Executive Officer | 66 | 04-12-31 |
Chig Fung Cheng
DFI | Director of Finance/CFO | 57 | 08-06-30 |
Michael Shi
CTO | Chief Tech/Sci/R&D Officer | 59 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chi Keung To
CHM | Chairman | 72 | 99-12-31 |
Graeme Jack
BRD | Director/Board Member | 73 | 17-02-28 |
Dan Eldar
BRD | Director/Board Member | 70 | 16-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 4 M€ | -4.41% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 352 | +4.14% | 243,766 |
24-05-09 | 338 | +7.99% | 343,723 |
24-05-08 | 313 | +1.62% | 151,038 |
24-05-07 | 308 | -0.65% | 45,426 |
Delayed Quote London S.E., May 10, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+24.38% | 3.76B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- HCM Stock